These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10052913)

  • 1. In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
    Kariyama R; Kumon H; Chow L; Zervos MJ; Takata T; Tabata M; Chow JW
    J Antimicrob Chemother; 1998 Dec; 42(6):836-8. PubMed ID: 10052913
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
    Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
    Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
    Messick CR; Woodward J; Pendland SL
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical speciation of enterococci causing human infections.
    Gulati V; Aggarwal A; Khanna S; Narang VK
    Indian J Med Sci; 1997 Sep; 51(9):310-2. PubMed ID: 9567508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals.
    Simonsen GS; Småbrekke L; Monnet DL; Sørensen TL; Møller JK; Kristinsson KG; Lagerqvist-Widh A; Torell E; Digranes A; Harthug S; Sundsfjord A
    J Antimicrob Chemother; 2003 Feb; 51(2):323-31. PubMed ID: 12562698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci.
    Chow JW; Donabedian SM; Clewell DB; Sahm DF; Zervos MJ
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):141-6. PubMed ID: 9884829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
    Landman D; Mobarakai NK; Quale JM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1904-8. PubMed ID: 8239604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level gentamicin-resistant enterococci: in vitro activity of double and triple combinations of antimicrobial drugs.
    Ferrara A; Dos Santos C; Cimbro M
    Chemotherapy; 1996; 42(1):37-46. PubMed ID: 8751265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
    Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
    J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low recovery rates of high-level aminoglycoside-resistant enterococci could be attributable to restricted usage of aminoglycosides in Indian settings.
    Sekar R; Srivani R; Vignesh R; Kownhar H; Shankar EM
    J Med Microbiol; 2008 Mar; 57(Pt 3):397-398. PubMed ID: 18287308
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
    Guirguitzova B; Chankova D; Zozikov B; Minkov N
    Ann Urol (Paris); 1998; 32(1):15-9. PubMed ID: 9559070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of quinupristin/dalfopristin and newer quinolones combined with gentamicin against resistant isolates of Enterococcus faecalis and Enterococcus faecium.
    Giamarellos-Bourboulis EJ; Sambatakou H; Grecka P; Giamarellou H
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):657-61. PubMed ID: 9832270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
    J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
    Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
    J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of high level aminoglycoside and vancomycin resistance among enterococci in Turkey.
    Cirak MY; Sultan N
    Acta Microbiol Pol; 1998; 47(3):267-73. PubMed ID: 9990710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci.
    Silverman J; Thal LA; Perri MB; Bostic G; Zervos MJ
    J Clin Microbiol; 1998 Mar; 36(3):830-2. PubMed ID: 9508325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic diversity of enterococci harboring the high-level gentamicin resistance gene aac(6')-Ie-aph(2'')-Ia or aph(2'')-Ie in a Japanese hospital.
    Watanabe S; Kobayashi N; Quiñones D; Nagashima S; Uehara N; Watanabe N
    Microb Drug Resist; 2009 Sep; 15(3):185-94. PubMed ID: 19728776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.